Evidence map›Paper›PMID 27377972›Full record

ArticleJournal of neuroscience research2016

Transparent reporting for reproducible science.

Tracey L Weissgerber, Vesna D Garovic, Stacey J Winham, Natasa M Milic, Eric M Prager

Abstract readEditorial
In one paragraph

Article in Journal of neuroscience research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Diabetes and Behavior in the 21st Century: Things That Make You Go "Hmmm . . . ".Diabetes spectrum : a publication of the American Diabetes Association · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tracey L WeissgerberDivision of Nephrology & Hypertension, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905.
Vesna D GarovicDivision of Nephrology & Hypertension, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905.
Stacey J WinhamDivision of Biomedical Statistics & Informatics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905.
Natasa M MilicDivision of Nephrology & Hypertension, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905.
Eric M PragerJohn Wiley & Sons, Inc, 111 River St, Hoboken, New Jersey, 07030.

Funding

Mayo Clinic Interdisciplinary Women's Health Research ProgramK12HD065987 · NICHD · MAYO CLINIC ROCHESTER · PI KANTARCI, KEJAL · 2010 to 2023
$6.7M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
NIA NIH HHS P50 AG044170NICHD NIH HHS K12 HD065987
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Reproducibility of ResultsAnimalsData Interpretation, StatisticalHumansPeer Review, ResearchResearch Design

Identifiers

PMID27377972
PMCPMC5330667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.